<unk>  is metabolized mainly by the cytochrome P450 enzyme CYP3A4, and for this reason, inhibitors and inducers of CYP3A4 can alter the amount of exposure to<unk>  when administered concomitantly with it. (For a list of CYP3A4 inhibitors and inducers, see here.) The strong CYP3A4 inhibitors ketoconazole and erythromycin have been found to increase exposure to<unk>  by up to 3-fold, whereas the strong CYP3A4 inducer rifampicin (rifampin) was found to decrease steady-state and area-under-curve concentrations of<unk>  by 50% and 80%, respectively.
Dienogest
Nafarelin
Estropipate
Degarelix
Protollin
Gestodene
Tesamorelin
Macimorelin